Ingino C, Farsang C, Laucevicius A, Bergovec M. An open-label study investigating the efficacy and safety of 12-96 weeks of telmisartan treatment in patients with hypertension. J Int Med Res. 2003 Nov;31(6):561–74. doi: 10.1177/147323000303100613. PMID: 14708422.